<DOC>
	<DOCNO>NCT00955526</DOCNO>
	<brief_summary>The purpose study establish efficacy 20 mg/day 40 mg/day dos istradefylline reduce mean total hour awake time per day spend OFF state patient advance Parkinson 's disease ( PD ) treat levodopa . Patients meet entry criterion randomize 1:1:1 ratio double blind treatment oral dose 20 40 mg/day istradefylline match placebo . Patients treat 12 week interim visit end treatment visit ass efficacy safety istradefylline .</brief_summary>
	<brief_title>Study KW-6002 ( Istradefylline ) Treatment Parkinson 's Disease Patients Taking Levodopa</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Istradefylline</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>1 . Be willing able give write informed consent 2 . UK Parkinson 's Disease Society ( UKPDS ) brain bank criterion ( Step 1 2 ) PD 3 . PD stag 24 OFF state Modified Hoehn Yahr Scale 4 . On levodopa/dopadecarboxylase inhibitor least one year 5 . Taking least three dos &gt; =300 mg levodopa/dopadecarboxylase inhibitor per day least four week randomization 6 . Predictable end dose wear 7 . Able satisfactorily complete Hauser base 24hour patient Parkinson 's diary 8 . Have average two hour OFF time 24hour diary 9 . On stable regimen antiParkinson 's drug least four week randomization 10 . On stable dose domperidone least 14 day randomization 1 . Taking excluded medication 2 . Neurosurgical treatment Transcranial Magnetic Stimulation PD 3 . Diagnosis cancer within 5 year 4 . Diagnosis clinically significant illness organ system 5 . Diagnosis dementia minimental status examination score 23 less 6 . History drug alcohol abuse dependence within past two year 7 . History psychosis 8 . History significant drug allergy 9 . Taking anticonvulsant seizures 10 . History neuroleptic malignant syndrome 11 . Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>levodopa</keyword>
	<keyword>end dose wear</keyword>
	<keyword>OFF time</keyword>
</DOC>